Prevalence and temporal trends of exposure to anti-obesity medications during preconception and pregnancy in a nationwide US claims database, 2018–2023
Prevalence and temporal trends of exposure to anti-obesity medications during preconception and pregnancy in a nationwide US claims database, 2018–2023. // European Journal of Obstetrics & Gynecology and Reproductive Biology. – URL: https://www.sciencedirect.com/science/article/pii/S0301211526005713?dgcid=rss_sd_all
Prevalence and temporal trends of exposure to anti-obesity medications during preconception and pregnancy in a nationwide US claims database, 2018–2023. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://www.sciencedirect.com/science/article/pii/S0301211526005713?dgcid=rss_sd_all
“Prevalence and temporal trends of exposure to anti-obesity medications during preconception and pregnancy in a nationwide US claims database, 2018–2023.” European Journal of Obstetrics & Gynecology and Reproductive Biology.
@article{article45106,
title = {Prevalence and temporal trends of exposure to anti-obesity medications during preconception and pregnancy in a nationwide US claims database, 2018–2023},
journal = {European Journal of Obstetrics \& Gynecology and Reproductive Biology},
url = {https://www.sciencedirect.com/science/article/pii/S0301211526005713?dgcid=rss_sd_all}
}